Skip to main content
. 2022 Jun 9;14(12):2854. doi: 10.3390/cancers14122854

Figure 2.

Figure 2

Comparison RFS between CP-GEP and EORTC nomogram in stage I–II melanoma. Because ulceration and/or anatomical site of the primary melanoma was unknown, 7 patients were excluded from the EORTC nomogram (n = 528 instead of n = 535 included for CP-GEP). Abbreviations: CP-GEP, clinicopathologic and gene expression profile; EORTC, European Organization for Research and Treatment of Cancer; RFS, recurrence-free survival; SLNB, sentinel lymph node biopsy; 95% CI, 95% confidence interval.